TOOsonix A/S Revolutionizes Dermatologic Therapy in Europe

TOOsonix A/S, a prominent developer of high-intensity focused ultrasound (HIFU) technology for dermatology, has achieved CE certification for its innovative System ONE-M™ under the EU Medical Device Regulation. This milestone allows TOOsonix to introduce its flagship product across the European Economic Area, transforming the treatment of various skin conditions.

The System ONE-M™ represents a significant advancement in dermatologic therapy, enabling the rapid and effective treatment of skin cancer, pre-cancerous lesions, and benign skin conditions in a single session. By incorporating cutting-edge imaging technology, healthcare providers can precisely target and address skin irregularities, eliminating the necessity for multiple specialized instruments.

Distinct from conventional dermatological procedures, treatments with System ONE-M™ are non-invasive, ensuring minimal discomfort and no recovery time for patients. The device caters to a diverse array of dermatologic requirements, including addressing basal cell carcinoma, actinic keratosis, and cutaneous neurofibromas in individuals with Neurofibromatosis Type 1.

Emphasizing the enhancement of patient care, TOOsonix strives to establish new benchmarks in dermatological therapy by offering safe, efficient, and effective treatment alternatives. Clinical evidence supporting the utilization of System ONE-M™ underscores its capacity to deliver optimal therapeutic results in under 90 seconds, presenting a convenient and patient-centric approach to managing dermatologic conditions.

Through global collaboration with healthcare practitioners, TOOsonix is committed to advancing dermatological care and enhancing the quality of life for patients. The company's dedication to harnessing focused ultrasound technology underscores its mission to cultivate a healthier future for individuals grappling with skin diseases.

TOOsonix's System ONE-M™ represents a groundbreaking advancement in dermatologic therapy, offering a swift, precise, and patient-friendly solution for a spectrum of skin conditions. With a focus on innovation and patient well-being, TOOsonix is poised to redefine standards in dermatological care, ushering in a new era of effective and accessible treatment options.